中國鋁業(02600.HK)擬開展貨幣類金融衍生業務
格隆匯3月22日丨中國鋁業(02600.HK)公吿,中國鋁業股份有限公司(以下簡稱「公司」)於2022年3月22日召開的第七屆董事會第二十六次會議審議批准了《關於公司2022年貨幣類金融衍生業務年度計劃的議案》,同意公司部分附屬公司開展2022年貨幣類金融衍生業務,總額度不超過15.17億美元。
公司部分附屬公司長期經營進出口業務,為應對國際市場變化,規避匯率波動風險,減小匯率波動對企業利潤的影響,實現企業穩健經營,故擬開展貨幣類金融衍生業務,以合理控制進出品業務中產生的匯率風險敞口。業務期限:2022年4月1日至2023年3月31日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.